SRD5A Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of SRD5A monoclonal antibodies for research in steroid metabolism. SRD5A monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SRD5A, or steroid 5-alpha-reductase, plays a crucial role in the conversion of testosterone to dihydrotestosterone (DHT), a potent androgen involved in various physiological processes. Understanding SRD5A function is essential for studying conditions such as androgenetic alopecia, benign prostatic hyperplasia, and certain forms of prostate cancer. The regulation of SRD5A activity has significant implications for hormonal therapies and drug development. Researchers worldwide rely on SRD5A monoclonal antibodies to advance their understanding of steroid metabolism pathways. Current investigations focus on how SRD5A influences hormone-dependent conditions and potential therapeutic interventions. SRD5A research continues to reveal new insights into endocrine system regulation and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to the advancement of steroid metabolism research and therapeutic development.